Anti anxiety medication efficacy
Pro Research Analysisby 
Searched over 200M research papers
Efficacy of Anti-Anxiety Medications: SSRIs, SNRIs, and Benzodiazepines
Research consistently shows that selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and benzodiazepines are the most commonly prescribed medications for anxiety disorders, especially generalized anxiety disorder (GAD) 1456. Meta-analyses indicate that all three classes are effective, but benzodiazepines tend to have a slightly higher effect size compared to SSRIs and SNRIs for adults with GAD 14. Antidepressants (SSRIs and SNRIs) are more effective than placebo in reducing anxiety symptoms, with a number needed to treat (NNT) of about 7 for a significant response .
Antidepressants for Anxiety: Efficacy and Considerations
Antidepressants, particularly SSRIs and SNRIs, are considered first-line treatments for anxiety disorders due to their efficacy and tolerability 456. Their benefit over placebo is well established, and they are effective regardless of the initial severity of anxiety symptoms, meaning they can be prescribed to patients with mild or severe anxiety 35. However, while antidepressants are generally well tolerated, they are associated with a higher rate of discontinuation due to side effects compared to placebo . Reporting biases in published studies may slightly overestimate their efficacy, but the difference is not statistically significant .
Benzodiazepines: Effectiveness and Limitations
Benzodiazepines show a moderate to high effect size in reducing anxiety symptoms and are often more effective than SSRIs and SNRIs in the short term 14. However, concerns about dependence, tolerance, and side effects limit their long-term use 69. They are typically reserved for short-term management or for patients who do not respond to other treatments.
Antipsychotics and Other Medications in Anxiety Disorders
Antipsychotics, both typical and atypical, are sometimes used off-label for anxiety disorders, especially as adjuncts to antidepressants in treatment-resistant cases 279. Evidence for their efficacy is limited, with only a few well-designed studies showing benefit, mainly for specific agents like trifluoperazine in GAD and quetiapine in some cases 27. The risks and side effects of antipsychotics, especially with long-term use, require careful consideration 79.
Other medications, such as buspirone, antihistamines, and beta-blockers, may be used in certain situations, but the evidence for their efficacy is less robust compared to SSRIs, SNRIs, and benzodiazepines .
Pediatric Anxiety: Medication Efficacy
In children and adolescents, SSRIs are the most effective class for reducing anxiety symptoms and increasing the likelihood of treatment response compared to placebo . SNRIs and alpha-2 agonists also show some benefit, but SSRIs are generally preferred due to their higher efficacy .
Combined and Alternative Treatments
Combining cognitive behavioral therapy (CBT) with medication can be as effective as medication alone, and sometimes more effective, especially for severe or treatment-resistant anxiety . While medications generally show higher effect sizes than psychotherapies alone, the choice between medication, therapy, or a combination should be individualized based on patient preference, side effect profiles, and comorbidities 46.
Conclusion
Anti-anxiety medications, particularly SSRIs, SNRIs, and benzodiazepines, are effective for treating anxiety disorders, with benzodiazepines showing the highest short-term efficacy but greater risks. Antidepressants are effective regardless of symptom severity and are generally well tolerated, though side effects can lead to discontinuation. Antipsychotics may be considered in specific, treatment-resistant cases, but evidence is limited. In pediatric populations, SSRIs are the most effective. The choice of treatment should be tailored to the individual, considering efficacy, side effects, and patient preferences.
Sources and full results
Most relevant research papers on this topic